Abstract | BACKGROUND: METHODS: Multiple databases from 1 January 2019 to 3 December 2020 were searched for observational studies evaluating the association between vitamin D deficiency and severity of COVID-19 infection. Independent reviewers selected studies and extracted data for the review. The main outcomes of interest were mortality, hospital admission, length of hospital stay and intensive care unit admission. RESULTS: Seventeen observational studies with 2756 patients were included in the analyses. Vitamin D deficiency was associated with significantly higher mortality (odds ratio [OR]: 2.47, 95% confidence interval [CI]: 1.50-4.05; 12 studies; hazard ratio [HR]: 4.11, 95% CI: 2.40-7.04; 3 studies), higher rates of hospital admissions (OR: 2.18, 95% CI: 1.48-3.21; 3 studies) and longer hospital stays (0.52 days; 95% CI: 0.25-0.80; 2 studies) as compared to nonvitamin D deficient status. Subgroup analyses based on different cut-offs for defining vitamin D deficiency, study geographic locations and latitude also showed similar trends. CONCLUSIONS:
|
Authors | Zhen Wang, Avni Joshi, Kaitlin Leopold, Sarah Jackson, Stephanie Christensen, Tarek Nayfeh, Khaled Mohammed, Ana Creo, Peter Tebben, Seema Kumar |
Journal | Clinical endocrinology
(Clin Endocrinol (Oxf))
Vol. 96
Issue 3
Pg. 281-287
(03 2022)
ISSN: 1365-2265 [Electronic] England |
PMID | 34160843
(Publication Type: Journal Article, Meta-Analysis, Systematic Review)
|
Copyright | © 2021 John Wiley & Sons Ltd. |
Chemical References |
|
Topics |
- COVID-19
- Humans
- Intensive Care Units
- SARS-CoV-2
- Vitamin D
- Vitamin D Deficiency
(complications)
|